Market Cap 5.28B
Revenue (ttm) 5.00B
Net Income (ttm) 211.82M
EPS (ttm) N/A
PE Ratio 22.23
Forward PE 21.46
Profit Margin 4.24%
Debt to Equity Ratio 0.86
Volume 1,867,500
Avg Vol 2,118,958
Day's Range N/A - N/A
Shares Out 158.73M
Stochastic %K 89%
Beta 0.80
Analysts Strong Sell
Price Target $35.80

Company Profile

Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapy and services; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, includin...

Industry: Medical Care Facilities
Sector: Healthcare
Phone: 312 940 2443
Address:
3000 Lakeside Drive, Suite 300N, Bannockburn, United States
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 12 at 12:22 AM
Actionable Trade Alert for $OPCH: Market Context: $OPCH is currently trading at $32.97, showing strong momentum as indicated by an RSI of 80.48, suggesting it is overbought. The stock is above its 30-day (MA30) and 50-day (MA50) moving averages, which are at $29.21 and $28.56 respectively. The recent 60-day high of $33.64 indicates potential resistance. Directional Bias: Given the high RSI and proximity to the 60D high, we anticipate a possible pullback or consolidation before further upward movement. However, if momentum continues, it can push beyond recent highs. Trade Plan: - Suggested Entry: $32.97 - Stop Loss: $30.00 (approx. 8.9% below entry) - Take Profit Targets: 1. $34.00 (3.1% gain) 2. $36.00 (9.2% gain) 3. $38.50 (17.3% gain) This plan allows for a potential ROI of over 17% on the third target while maintaining a manageable risk. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
JarvisFlow
JarvisFlow Dec. 11 at 9:37 AM
Stephens & Co. updates rating for Option Care Health ( $OPCH ) to Overweight, target set at 40.
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 10 at 4:25 AM
Actionable Trade Alert for $OPCH: Market Context: $OPCH is currently trading at $32.22, nearing its 60-day high of $32.55. The RSI at 75.32 indicates overbought conditions, suggesting potential price pullbacks. However, the stock is above its 30-day MA of $28.90 and 50-day MA of $28.34, indicating a bullish trend. Directional Bias: Despite the overbought RSI, the strong support from the moving averages and proximity to the recent high suggest a bullish bias in the short term. Trade Plan: - Suggested Entry: $32.22 - Stop Loss: $30.50 (approximately 5.3% below entry) - Take Profit Targets: 1. $33.00 (2.4% gain) 2. $34.00 (5.4% gain) 3. $37.80 (17.3% gain) With the potential for a 17% ROI at target 3, this trade presents a favorable risk-reward ratio. Monitor RSI for signs of reversal before entering. https://privateprofiteers.com
0 · Reply
BillionerOfKing
BillionerOfKing Dec. 9 at 7:56 PM
$OPCH Current Stock Price: $32.14 Contracts to trade: $30 OPCH Dec 19 2025 Call Entry: $2.25 Exit: $3.28 ROI: 46% Hold ~30 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
JarvisFlow
JarvisFlow Dec. 9 at 5:50 PM
B of A Securities has updated their rating for Option Care Health ( $OPCH ) to Buy with a price target of 35.
0 · Reply
AlphaBullRider
AlphaBullRider Dec. 9 at 5:48 PM
$OPCH $CVS Top winners in healthcare. $GDRX $HUM Top losers. Otherwise, healthcare is mostly flat today. I'm most interested in $UNH
0 · Reply
JarvisFlow
JarvisFlow Dec. 9 at 5:03 PM
Deutsche Bank has adjusted their stance on Option Care Health ( $OPCH ), setting the rating to Buy with a target price of 31 → 36.
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 9 at 12:13 AM
Actionable Trade Alert for $OPCH: Market Context: $OPCH is currently trading at $30.24, nearing its 60-day high of $31.51, indicating bullish momentum. The RSI at 67.84 suggests the stock is approaching overbought territory, but there's still room for upward movement. Directional Bias: The stock's price is above both the 30-day MA (28.75) and the 50-day MA (28.24), confirming a bullish trend. The recent price action is strong, and the distance from the 60-day low (24.24) supports potential for further gains. Trade Plan: - Suggested Entry: $30.24 - Stop Loss: $28.50 (approximately 5.8% below entry) - Take Profit Targets: 1. $31.00 (Target 1, approx. 2.5% gain) 2. $32.00 (Target 2, approx. 5.8% gain) 3. $35.50 (Target 3, approx. 17% gain) This plan aims for a minimum 17% ROI on Target 3 while maintaining a controlled risk. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 6 at 3:12 AM
Actionable Trade Alert for $OPCH: Market Context: $OPCH is currently trading at $29.9, showing a strong position relative to its recent performance. The RSI at 58.45 indicates bullish momentum, while the price is above both the 30-day MA (28.61) and the 50-day MA (28.12), suggesting a positive trend. Directional Bias: The stock is in a bullish phase as it approaches the 60-day high of $31.51, with the potential for upward movement given the recent price action and RSI positioning. Trade Plan: - Suggested Entry: $29.90 - Stop Loss: $28.50 (1.7% below entry) - Take Profit Targets: - TP1: $30.50 (2% gain) - TP2: $31.00 (3.7% gain) - TP3: $34.90 (17% gain) This plan offers a solid risk-reward ratio with a potential 17% ROI on TP3. Monitor the stock closely for any changes in momentum. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 5 at 10:47 PM
Actionable Trade Alert for $OPCH: Market Context: $OPCH is currently trading at $29.9, showing a strong position relative to its recent performance. The RSI at 58.45 indicates bullish momentum, while the price is above both the 30-day MA (28.61) and the 50-day MA (28.12), suggesting a positive trend. Directional Bias: The stock is in a bullish phase as it approaches the 60-day high of $31.51, with the potential for upward movement given the recent price action and RSI positioning. Trade Plan: - Suggested Entry: $29.90 - Stop Loss: $28.50 (1.7% below entry) - Take Profit Targets: - TP1: $30.50 (2% gain) - TP2: $31.00 (3.7% gain) - TP3: $34.90 (17% gain) This plan offers a solid risk-reward ratio with a potential 17% ROI on TP3. Monitor the stock closely for any changes in momentum. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
Latest News on OPCH
Option Care Health Announces Chief Financial Officer Transition

Aug 20, 2025, 8:45 AM EDT - 4 months ago

Option Care Health Announces Chief Financial Officer Transition


Option Care (OPCH) Q2 Revenue Jumps 15%

Jul 31, 2025, 3:57 PM EDT - 4 months ago

Option Care (OPCH) Q2 Revenue Jumps 15%


Option Care Health, Inc. (OPCH) Q2 2025 Earnings Call Transcript

Jul 30, 2025, 12:01 PM EDT - 4 months ago

Option Care Health, Inc. (OPCH) Q2 2025 Earnings Call Transcript


Option Care Health, Inc. (OPCH) Q1 2025 Earnings Call Transcript

Apr 29, 2025, 12:29 PM EDT - 8 months ago

Option Care Health, Inc. (OPCH) Q1 2025 Earnings Call Transcript


Option Care Health, Inc. (OPCH) Q4 2024 Earnings Call Transcript

Feb 26, 2025, 1:16 PM EST - 10 months ago

Option Care Health, Inc. (OPCH) Q4 2024 Earnings Call Transcript


Option Care Health: A Deep Dive Into Its Market Dominance

May 31, 2024, 11:50 AM EDT - 1 year ago

Option Care Health: A Deep Dive Into Its Market Dominance


Option Care Health says it is affected by UnitedHealth hack

Mar 14, 2024, 5:04 PM EDT - 1 year ago

Option Care Health says it is affected by UnitedHealth hack

UNH


Why Option Care Health Stock Plummeted Today

Oct 25, 2023, 7:05 PM EDT - 2 years ago

Why Option Care Health Stock Plummeted Today


PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 12 at 12:22 AM
Actionable Trade Alert for $OPCH: Market Context: $OPCH is currently trading at $32.97, showing strong momentum as indicated by an RSI of 80.48, suggesting it is overbought. The stock is above its 30-day (MA30) and 50-day (MA50) moving averages, which are at $29.21 and $28.56 respectively. The recent 60-day high of $33.64 indicates potential resistance. Directional Bias: Given the high RSI and proximity to the 60D high, we anticipate a possible pullback or consolidation before further upward movement. However, if momentum continues, it can push beyond recent highs. Trade Plan: - Suggested Entry: $32.97 - Stop Loss: $30.00 (approx. 8.9% below entry) - Take Profit Targets: 1. $34.00 (3.1% gain) 2. $36.00 (9.2% gain) 3. $38.50 (17.3% gain) This plan allows for a potential ROI of over 17% on the third target while maintaining a manageable risk. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
JarvisFlow
JarvisFlow Dec. 11 at 9:37 AM
Stephens & Co. updates rating for Option Care Health ( $OPCH ) to Overweight, target set at 40.
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 10 at 4:25 AM
Actionable Trade Alert for $OPCH: Market Context: $OPCH is currently trading at $32.22, nearing its 60-day high of $32.55. The RSI at 75.32 indicates overbought conditions, suggesting potential price pullbacks. However, the stock is above its 30-day MA of $28.90 and 50-day MA of $28.34, indicating a bullish trend. Directional Bias: Despite the overbought RSI, the strong support from the moving averages and proximity to the recent high suggest a bullish bias in the short term. Trade Plan: - Suggested Entry: $32.22 - Stop Loss: $30.50 (approximately 5.3% below entry) - Take Profit Targets: 1. $33.00 (2.4% gain) 2. $34.00 (5.4% gain) 3. $37.80 (17.3% gain) With the potential for a 17% ROI at target 3, this trade presents a favorable risk-reward ratio. Monitor RSI for signs of reversal before entering. https://privateprofiteers.com
0 · Reply
BillionerOfKing
BillionerOfKing Dec. 9 at 7:56 PM
$OPCH Current Stock Price: $32.14 Contracts to trade: $30 OPCH Dec 19 2025 Call Entry: $2.25 Exit: $3.28 ROI: 46% Hold ~30 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
JarvisFlow
JarvisFlow Dec. 9 at 5:50 PM
B of A Securities has updated their rating for Option Care Health ( $OPCH ) to Buy with a price target of 35.
0 · Reply
AlphaBullRider
AlphaBullRider Dec. 9 at 5:48 PM
$OPCH $CVS Top winners in healthcare. $GDRX $HUM Top losers. Otherwise, healthcare is mostly flat today. I'm most interested in $UNH
0 · Reply
JarvisFlow
JarvisFlow Dec. 9 at 5:03 PM
Deutsche Bank has adjusted their stance on Option Care Health ( $OPCH ), setting the rating to Buy with a target price of 31 → 36.
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 9 at 12:13 AM
Actionable Trade Alert for $OPCH: Market Context: $OPCH is currently trading at $30.24, nearing its 60-day high of $31.51, indicating bullish momentum. The RSI at 67.84 suggests the stock is approaching overbought territory, but there's still room for upward movement. Directional Bias: The stock's price is above both the 30-day MA (28.75) and the 50-day MA (28.24), confirming a bullish trend. The recent price action is strong, and the distance from the 60-day low (24.24) supports potential for further gains. Trade Plan: - Suggested Entry: $30.24 - Stop Loss: $28.50 (approximately 5.8% below entry) - Take Profit Targets: 1. $31.00 (Target 1, approx. 2.5% gain) 2. $32.00 (Target 2, approx. 5.8% gain) 3. $35.50 (Target 3, approx. 17% gain) This plan aims for a minimum 17% ROI on Target 3 while maintaining a controlled risk. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 6 at 3:12 AM
Actionable Trade Alert for $OPCH: Market Context: $OPCH is currently trading at $29.9, showing a strong position relative to its recent performance. The RSI at 58.45 indicates bullish momentum, while the price is above both the 30-day MA (28.61) and the 50-day MA (28.12), suggesting a positive trend. Directional Bias: The stock is in a bullish phase as it approaches the 60-day high of $31.51, with the potential for upward movement given the recent price action and RSI positioning. Trade Plan: - Suggested Entry: $29.90 - Stop Loss: $28.50 (1.7% below entry) - Take Profit Targets: - TP1: $30.50 (2% gain) - TP2: $31.00 (3.7% gain) - TP3: $34.90 (17% gain) This plan offers a solid risk-reward ratio with a potential 17% ROI on TP3. Monitor the stock closely for any changes in momentum. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 5 at 10:47 PM
Actionable Trade Alert for $OPCH: Market Context: $OPCH is currently trading at $29.9, showing a strong position relative to its recent performance. The RSI at 58.45 indicates bullish momentum, while the price is above both the 30-day MA (28.61) and the 50-day MA (28.12), suggesting a positive trend. Directional Bias: The stock is in a bullish phase as it approaches the 60-day high of $31.51, with the potential for upward movement given the recent price action and RSI positioning. Trade Plan: - Suggested Entry: $29.90 - Stop Loss: $28.50 (1.7% below entry) - Take Profit Targets: - TP1: $30.50 (2% gain) - TP2: $31.00 (3.7% gain) - TP3: $34.90 (17% gain) This plan offers a solid risk-reward ratio with a potential 17% ROI on TP3. Monitor the stock closely for any changes in momentum. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
Estimize
Estimize Nov. 24 at 1:03 PM
Wall St is expecting 0.46 EPS for $OPCH Q4 [Reporting 02/19 BMO] http://www.estimize.com/intro/opch?chart=historical&metric_name=eps&utm_co
0 · Reply
ADSlay
ADSlay Nov. 11 at 12:05 AM
$QNCX "Are these reviews even worth it", I asked (you should too) $QNCX will surprise us all Dirk, Charles and Brandon are a formidable trio on a mission. Look how they got us $OPCH partnership. We will be sipping colored-umbrella mai tais by the ocean in 2026. Watch!
1 · Reply
BEATOFtheMARKET
BEATOFtheMARKET Nov. 6 at 4:19 PM
0 · Reply
BillionerOfKing
BillionerOfKing Nov. 4 at 3:39 PM
$OPCH Current Stock Price: $27.00 Contracts to trade: $30 OPCH Nov 21 2025 Call Entry: $0.20 Exit: $0.25 ROI: 26% Hold ~29 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
JarvisFlow
JarvisFlow Nov. 3 at 4:26 PM
TD Cowen has updated their rating for Option Care Health ( $OPCH ) to Hold with a price target of 27.
0 · Reply
Invest2live
Invest2live Oct. 31 at 3:55 PM
$OPCH don’t lose your cheap shares; this has longterm value.
0 · Reply
OptionRunners
OptionRunners Oct. 29 at 5:06 PM
$OPCH Buyer of the November 21st $30/$25 bull risk reversals 3,000 times for $0.65 ahead of earnings tomorrow morning
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Oct. 29 at 3:40 PM
$OPCH RSI: 74.04, MACD: 0.0829 Vol: 0.57, MA20: 27.57, MA50: 27.97 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
ADSlay
ADSlay Oct. 24 at 4:26 PM
$QNCX there are big 'reputation' costs associated for public companies to be partnering with others. They don't just randomly partner with small companies unless there is moat, especially not with someone like $QNCX who is a turnaround story, pre-revenue, and no proven product. I am sure $OPCH must've agreed to partner only after performing their thorough due-diligence. yes, no one refuses extra revenue coming in, but when you're a responsible $5 billion publicly traded company, you don't just randomly partner with anyone. there is a 'brand' image they've to protect.
0 · Reply
ADSlay
ADSlay Oct. 23 at 5:03 PM
$QNCX Anything can happen in biotech world, but why would a $5 billion company like $OPCH agree to a strategic partnership with a $100 million company like $QNCX? That alone makes $QNCX a great risk:reward opportunity besides being a Ph3 asset that has full Regulatory support from FDA.
2 · Reply
ADSlay
ADSlay Oct. 23 at 1:12 PM
Thanks for sharing. Yes, $QNCX Management regularly updates their presentation and is a great resource for research. Why would a $5 billion company associate with a $100 million company? Think why $OPCH would partner with $QNCX ? When one is such a big company, one doesn't associate with random biotech microcaps with unproven product. Think about it.
1 · Reply
Estimize
Estimize Oct. 22 at 12:06 PM
Wall St is expecting 0.43 EPS for $OPCH Q3 [Reporting 10/30 BMO] http://www.estimize.com/intro/opch?chart=historical&metric_name=eps&utm_co
0 · Reply